Bristol-Myers Hits Mylan With Suit Over Generic HIV Drug
Bristol-Myers Squibb Co. and Mylan Pharmaceuticals Inc. are once again battling over HIV treatment Reyataz, with BMS filing a suit in West Virginia federal court Thursday to stop a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article